BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3923527)

  • 1. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
    Wender PH; Wood DR; Reimherr FW
    Psychopharmacol Bull; 1985; 21(2):222-31. PubMed ID: 3923527
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
    Wender PH
    J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK; Julius JR; Breen TJ; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulant treatment of adult attention-deficit/hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Psychiatr Clin North Am; 2004 Jun; 27(2):361-72. PubMed ID: 15064002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
    Akhondzadeh S; Tavakolian R; Davari-Ashtiani R; Arabgol F; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal brain dysfunctions in children.
    Peters JE
    Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
    Walkup JT; Scahill LD; Riddle MA
    Adv Neurol; 1995; 65():259-72. PubMed ID: 7872144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photic responses in "minimal brain dysfunction".
    Milstein V; Small JG
    Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
    [No Abstract]   [Full Text] [Related]  

  • 15. Pemoline and urinary excretion of catecholamines and indoleamines in children with attention deficit disorder.
    Zametkin AJ; Linnoila M; Karoum F; Sallee R
    Am J Psychiatry; 1986 Mar; 143(3):359-62. PubMed ID: 2420216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of methylphenidate in adults with attention deficit disorder with hyperactivity].
    Gauillard J; Castelnau C; Vacheron-Trystram MN; Cheref S; Caroli F
    Encephale; 1997; 23(4):251-6. PubMed ID: 9417389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MBD: advanced in understanding many bothersome dilemmas.
    Seals JR
    Adv Pediatr; 1976; 23():113-49. PubMed ID: 795279
    [No Abstract]   [Full Text] [Related]  

  • 18. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
    Conners CK
    Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
    [No Abstract]   [Full Text] [Related]  

  • 19. American Academy of Pediatrics Committee on Children with Disabilities, Committee on Drugs: Medication for children with an attention deficit disorder.
    Pediatrics; 1987 Nov; 80(5):758-60. PubMed ID: 3670981
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperactivity (attention-deficit disorder).
    Martin CA; Welsh RJ; McKay SE; Bareuther CM
    J Fam Pract; 1984 Sep; 19(3):367-9, 372-3, 376-7 passim. PubMed ID: 6381638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.